Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc.verified

AGNPF

Price:

$0.06025

Market Cap:

$1.84M

Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of non–alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19 in Canada and Australia. The company's lead candidate is NP-120, an N-methyl-d-aspartate (NMDA) receptor glutamate receptor antagonist, which targets NMDA-type subunit 2B (Glu2NB), as well as exhibits agonist activity for the Sigma-1 receptor, a chaperone protein up-regulated during endoplasmic reticulum stress. It is also developing AP-188, a psychedelic compound that is part of the tryptamine fami...[Read more]

Industry

Biotechnology

IPO Date

2016-03-11

Stock Exchange

PNK

Ticker

AGNPF

The ROE as of November 2024 (TTM) for Algernon Pharmaceuticals Inc. (AGNPF) is -213.50%

According to Algernon Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current ROE is -213.50%. This represents a change of 125.40% compared to the average of -94.72% of the last 4 quarters.

Algernon Pharmaceuticals Inc. (AGNPF) Historical ROE (quarterly & annually)

How has AGNPF ROE performed in the past?

The mean historical ROE of Algernon Pharmaceuticals Inc. over the last ten years is -147.96%. The current -213.50% ROE has changed 44.30% with respect to the historical average. Over the past ten years (40 quarters), AGNPF's ROE was at its highest in in the May 2024 quarter at 73.59%. The ROE was at its lowest in in the February 2024 quarter at -229.56%.

Quarterly (TTM)
Annual

Average

-147.96%

Median

-84.85%

Minimum

-460.07%

Maximum

-38.12%

Algernon Pharmaceuticals Inc. (AGNPF) ROE by Quarter and Year

Discovering the peaks and valleys of Algernon Pharmaceuticals Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 444.97%

Maximum Annual ROE = -38.12%

Minimum Annual Increase = -63.27%

Minimum Annual ROE = -460.07%

Quarterly (TTM)
Annual
YearROEChange
2023-460.07%327.42%
2022-107.64%26.86%
2021-84.85%21.40%
2020-69.89%83.34%
2019-38.12%-44.47%
2018-68.64%-42.31%
2017-119.00%-63.27%
2016-323.96%444.97%

Algernon Pharmaceuticals Inc. (AGNPF) Average ROE

How has AGNPF ROE performed in the past?

The current ROE of Algernon Pharmaceuticals Inc. (AGNPF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-217.52%

5-year avg

-152.11%

10-year avg

-147.96%

Algernon Pharmaceuticals Inc. (AGNPF) ROE vs. Peers

How is AGNPF’s ROE compared to its peers?

Algernon Pharmaceuticals Inc.’s ROE is greater than Cellectis S.A. (-81.02%), greater than Biotron Limited (-504.53%), less than Resverlogix Corp. (12.20%), greater than Small Pharma Inc. (-94.62%), greater than Covalon Technologies Ltd. (-4.23%), less than Adynxx, Inc. (0%), less than Ascletis Pharma Inc. (0%), less than BioCardia, Inc. (-0.89%), less than Wesana Health Holdings Inc. (526.79%), less than BioVaxys Technology Corp. (242.19%), less than GH Research PLC (322.77%), greater than AXIM Biotechnologies, Inc. (-16.39%), less than Bioasis Technologies Inc. (54.15%), less than Mosaic ImmunoEngineering Inc. (0%), less than Ceapro Inc. (5.79%), greater than null (-21.67%),

Build a custom stock screener for Algernon Pharmaceuticals Inc. (AGNPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Algernon Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Algernon Pharmaceuticals Inc. (AGNPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Algernon Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Algernon Pharmaceuticals Inc.'s ROE?

How is the ROE calculated for Algernon Pharmaceuticals Inc. (AGNPF)?

What is the highest ROE for Algernon Pharmaceuticals Inc. (AGNPF)?

What is the 3-year average ROE for Algernon Pharmaceuticals Inc. (AGNPF)?

What is the 5-year average ROE for Algernon Pharmaceuticals Inc. (AGNPF)?

How does the current ROE for Algernon Pharmaceuticals Inc. (AGNPF) compare to its historical average?